Endomag CEO features in Telegraph article about Brexit transition


Eric Mayes, CEO of Cambridge-based Endomag, tells The Telegraph that thorough preparation has made his firm future-proof, as businesses across the UK prepare for the end of the Brexit transition period on 31 December.

Read the article here (subscription required).


Endomag was founded to solve cancer staging and healthcare challenges through the application of advanced magnetic sensing technology and nanotechnology.